Skip to main content
. 2013 Apr 5;7:285–292. doi: 10.2147/PPA.S41929

Figure 1.

Figure 1

Overall confidence of all participants (PwD and HCP) in NP5 compared with HPL for management of daily insulin injections (PwD) or patients’ ability to manage their daily injections (HCP).

Note: *P < 0.001 NP5 vs HPL.

Abbreviations: HCP, health care professionals; HPL, HumaPen Luxura®; NP5, NovoPen® 5; PwD, patients with diabetes.